HTA110 Differences in the Reimbursement Pathway for Ultraorphan Therapies in England and Ireland
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1895
https://www.valueinhealthjournal.com/article/S1098-3015(25)04452-3/fulltext
Title :
HTA110 Differences in the Reimbursement Pathway for Ultraorphan Therapies in England and Ireland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04452-3&doi=10.1016/j.jval.2025.09.1895
First page :
Section Title :
Open access? :
No
Section Order :
11437